LINDEN ADVISORS LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAD3. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,466,026
-30.5%
43,274,000
-10.4%
0.35%
-32.1%
Q2 2023$49,616,921
+23.8%
48,274,000
+37.0%
0.52%
+23.5%
Q1 2023$40,079,804
+213.2%
35,247,000
+175.4%
0.42%
+214.9%
Q4 2022$12,795,060
+3.7%
12,800,000
+21.9%
0.13%
+18.6%
Q3 2022$12,335,000
+2263.0%
10,500,000
+2000.0%
0.11%
+2160.0%
Q2 2022$522,000500,0000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 45,200,000$51,456,1323.35%
CSS LLC/IL 17,945,000$20,505,4821.35%
READYSTATE ASSET MANAGEMENT LP 12,000,000$13,644,0001.27%
Boussard & Gavaudan Investment Management LLP 8,527$9,707,4530.91%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 32,000,000$36,310,7200.81%
LINDEN ADVISORS LP 35,247,000$40,079,8040.42%
WHITEBOX ADVISORS LLC 1,000,000$1,132,0000.04%
FRANKLIN RESOURCES INC 63,000,000$71,631,0000.04%
D. E. Shaw & Co., Inc. 22,500,000$25,622,5750.03%
KORNITZER CAPITAL MANAGEMENT INC /KS 600,000$679,2000.01%
View complete list of PTC THERAPEUTICS INC shareholders